Refreshing results…
The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity
UploadTargeting TBK1 to overcome resistance to cancer immunotherapy
Download from www.nature.comSupporting the next generation of scientists to lead cancer immunology research
Download from aacrjournals.orgMigratory DCs activate TGF-β to precondition naïve CD8+ T cells for tissue-resident memory fate
UploadMissing publications? Search for publications with a matching author name.